RNA-based therapeutic for renal cell carcinoma/head and neck cancer/solid tumor(Versameb)

N/A

Report date: 2025/01/26 18:02:08
NME

Base Information

Drug NameRNA-based therapeutic for renal cell carcinoma/head and neck cancer/solid tumor(Versameb)
Drug Alias NameVERSagile platform technology (Versameb)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSolid tumoursHead and Neck NeoplasmsCarcinoma, Renal Cell +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVersameb AG
China Registration ClassN/A

Develop Information

Active CompaniesVersameb AG
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsHead and Neck NeoplasmsCarcinoma, Renal CellNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A